AXP vs RANI · P/E 20, rev $21.73B vs rev $3.4M
American Express Company (AXP) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. RANI currently screens at market cap $41.5M.
Not investment advice. Open the AXP and RANI stock pages for the full models.
Not investment advice.